|
SOPH Sophia Genetics SA 1840706 |
| Income Statement |
|
Net Income
|
2025-12-31
|
$-78,999,000.00 |
| Balance Sheet |
|
Current Assets
|
$99,079,000.00 |
|
Assets
|
$163,031,000.00 |
|
Current Liabilities
|
$50,528,000.00 |
|
Liabilities
|
$115,886,000.00 |
|
Equity
|
$47,145,000.00 |
|
Shares Out
|
68486338.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-35,893,000.00 |
|
Investing Cash Flow
|
$-8,670,000.00 |
| Market Analysis |
Market Cap
|
$394,481,306.88 |
|
Price
|
$5.76 |
|
BVPS
|
0.69 |
|
PB
|
8.35 |
|
EPS
|
-1.18 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:27 |
|
| Apr |
May |
Jun |
| 2026-03-03 |
-0.28 |
|
|
2026-05-05 |
-0.27 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-0.33 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
-0.30 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SOPH documents filed with the SEC.
SOPH Filings
Clear
